74Th Annual Meeting March 11 – 14, 2010 Loews Miami Beach Hotel Miami Beach, Florida
Total Page:16
File Type:pdf, Size:1020Kb
Southeastern Section of the American Urological Association, Inc. 74th Annual Meeting March 11 – 14, 2010 Loews Miami Beach Hotel Miami Beach, Florida In Memory of Victor Politano, MD (1919 – 2010) SESAUA President 1979 – 1980 AUA President 1985 – 1986 In humble recognition of Dr. Politano’s many contributions to the art and practice of urology, the 74th annual meeting of the SESAUA is formally dedicated to his memory. 1 Table of Contents Mission Statement, Needs, and Objectives ---------------------------------------3 CME Accreditation -----------------------------------------------------------------------4 SESAUA Contact Information --------------------------------------------------------5 Officers, Board of Directors, Standing and Special Committees of SESAUA------------------------------------------------------------------------------------6 Numerical Membership of the SESAUA -------------------------------------------10 General Meeting Information Registration -------------------------------------------------------------------15 Board of Directors and Committee Meetings -------------------------15 Convention Center Floor Plan --------------------------------------------16 Exhibit Hall Hours ------------------------------------------------------------17 Speaker Ready Room Hours ---------------------------------------------17 Spouse/Guest Hospitality Suite Hours ---------------------------------17 Annual Business Meeting --------------------------------------------------17 Evening/Optional/Sporting Events ---------------------------------------17 Exhibitors ----------------------------------------------------------------------------------22 Special Thanks to Sponsors ----------------------------------------------------------23 Named Lectures and Contests -------------------------------------------------------24 Scientific Sessions Thursday -----------------------------------------------------------------------26 Friday ---------------------------------------------------------------------------77 Saturday------------------------------------------------------------------------128 Sunday -------------------------------------------------------------------------153 Alphabetical Index of Presenters ----------------------------------------------------165 Minutes of the 73rd Annual Business Meeting of the SESAUA --------------169 Membership Candidates and Transfers --------------------------------------------177 Necrology Report ------------------------------------------------------------------------179 2009 Proposed Bylaws Changes ----------------------------------------------------181 Report of the SESAUA Representative to the AUA Board of Directors --------------------------------------------------------182 Preliminary SESAUA Treasurer’s Report for 2009 ------------------------------183 Roster of State Societies and Officers ---------------------------------------------184 Previous Officers and Annual Meeting Sites --------------------------------------185 Schedule for Future Meetings of the SESAUA -----------------------------------192 2 Southeastern Section of the American Urological Association, Inc. Mission Statement: To be the professional organization in the southeastern United States that fosters the highest standards of urologic care through education, research and socioeconomic awareness. SESAUA goals: • Support excellence in urologic care of patients • Education of urologists • Encourage research • Forum for presentation of: . Clinical interest . Clinical and basic research . Support the AUA in health care policy and share ideas with the AUA, Inc. Scientific Program SESAUA Secretary, Raymond J. Leveillee, MD has planned a dynamic program that is certain to provide practicing urologists cutting-edge information. Detailed information about the scientific program begins on page 25. Needs Assessment The Secretary of the SESAUA, consulted with other members of the Committee on Science and Education; the Executive Committee members, including the current SESAUA President, Dr. Thomas Stringer; and Dr. Elspeth McDougal, Director of the Office of Education of the AUA, regarding the needs we are attempting to fulfill through our annual scientific program. It was agreed by the above committee members, Section Officers and Director of the Office of Education of theAUA that there continues to be significant educational needs for our annual meeting and scientific program. Urologic abnormalities can present with a myriad of clinical symptoms and signs. Accurate differential diagnosis and disease management, which meets current standards of care, requires ongoing review of the presentations of various urologic abnormalities as well as the appropriate use of safe and cost-effective imaging modalities and various pharmacologic, minimally invasive, and operative management options. In addition, advancements in medical science and progress in management of various urologic diseases require basic and clinical research. Presentation and discussion of such peer-reviewed and Abstract Reviewer-selected summaries and results of investigations provide “cutting edge” updates for practicing clinicians and essential feedback to researchers on the practical applications and translation of their investigations to clinical practice. Educational Objectives At the conclusion of the meeting, participants should be able to: • Recognize clinical presentation and treatment options of various urologic abnormalities • Describe the various minimally invasive treatments for Urologic Diseases and their risk/ benefits • Apply Evidence Based Medicine (EBM) in urologic practice specifically incorporatingAUA Guidelines into daily practice • Understand the role of thermal therapies (e.g., Radiofrequency, Cryoablation, etc) in the treatment of urologic malignancies • Describe the process involved in creating Guidelines and Best practice policies with review of recently released documents • Identify basic laparoscopic applications and results in adult and pediatric patients • Analyze data pertaining to various pharmacologic and surgical treatments for voiding dysfunction and urinary incontinence • Recognize the latest diagnostic/treatment options for various renal anomalies • Indicate current management options for urolithiasis (EBM) • Understand new and modified treatments for erectile dysfunction, infertility, and penile malignancies • Identify results of various laparoscopic and robotic approaches and techniques for benign and malignant urologic diseases • Appraise research results and clinical series on management of prostate cancer and early diagnosis/screening in various patient populations • Describe common pediatric urologic diseases and treatment updates • Comprehend prognostic significance and treatments of various stages and grades of bladder cancer • Identify techniques and results of various forms of urinary diversion • Evaluate surgical techniques in video format to gain a greater understanding • Identify socioeconomic factors affecting urologic training and clinical practice • Design Wrap-up session to highlight current practice patterns.Understand the management issues pertaining to patients with Spinal cord injuries (SCI) and the unique urologic needs of such patients 3 74th Annual SESAUA Meeting March 11 – 14, 2010 Miami Beach, Florida CME Accreditation: The American Urological Association Education and Research, Inc. (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity. Credit Designation: The American Urological Association Education and Research, Inc. designates this educational activity for a maximum of 23.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. AUAER Disclosure Policy: As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AUAER must insure balance, independence, objectivity and scientific rigor in all its activities. All faculty participating in an educational activity provided by the AUAER are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUAER must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses are discussed, these are also indicated. Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of the AUAER to require the disclosure of all references to unlabeled or unapproved uses or drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the